Classic Industries Appoints Robert P. Subasic Jr New CEO

Latrobe, PA Aug 30, 2011 — Classic Industries has named Robert P. Subasic, Jr., its new CEO. Subasic succeeds CEO Joseph (Jay) Policastro, Jr., who will serve in a new role as Company Chairman.
Subasic is a seasoned manufacturing industry veteran who has held several senior executive and board positions. His operating experience from the beverage, metal fabrication and information technology industries, including business operations, marketing and financial management, will help him lead Classic Industries in its next stage of growth.

U.S. HealthWorks Becomes In-Network Medical Provider for Regence BlueShield/Asuris Members

Seattle, WA Aug 30, 2011 – U.S. HealthWorks Medical Group, the leading operator of urgent care and occupational healthcare centers in Washington, today announced that it will return to being an in-network medical provider for Regence BlueShield members in Puget Sound and Asuris members in Spokane effective Sept. 1.
U.S. HealthWorks Medical Group operates 17 medical centers in Washington – 14 in the Puget Sound area and three in the Spokane area – with many centers open 7 days a week. All centers accept walk-in patients with no appointment necessary.
“U.S. HealthWorks provides quality, convenient medical care when patients need it,” said Dr. Clyde Wilson, President of U.S. HealthWorks Medical Group of Washington. “So, we are pleased to once again be an in-network provider for Regence BlueShield and Asuris members and to deliver high-quality care to those patients.”
Regence BlueShield/Asuris provides insurance to about 780,000 members in Washington.
U.S. HealthWorks provides urgent care services, occupational healthcare services as well as physical therapy, chiropractic care, and massage therapy. The comprehensive occupational healthcare services include injury and illness diagnosis and treatment, pre-placement and post-offer physical exams, drug and alcohol testing, and physical therapy services.

Alterna LLC Launches Kerasal Nail, Fungal Nail Renewal Treatment

Whippany, NJ Aug 22, 2011 — Alterna LLC today announced the launch of Kerasal Nail – Fungal Nail Renewal Treatment, a new addition to the Kerasal® brand. Kerasal Nail is a topical formula that’s clinically proven to rapidly improve appearance of nails damaged or discolored by fungus and psoriasis. The product will be found on store shelves in the foot care aisle in major Walmart stores and Rite Aid stores this fall. Other major drug chains are expected to carry the product soon.
An estimated 30 million Americans suffer from unsightly and embarrassing nail appearance, a market currently underserved by nonprescription products. Kerasal Nail’s unique nail-penetrating formula has been licensed exclusively for the U.S. market from Moberg Derma AB, a leading Swedish pharmaceutical company. The product is already the #1 seller in various European countries where it launched last year.
Kerasal Nail’s patented formula combines the keratolyctic, nail softening, and hydrating effects of propylene glycol, urea and lactic acid to deeply penetrate the nail, and restore healthy appearance by normalizing thickened nails, reducing nail discoloration, and hydrating brittle nails. Kerasal Nail is odorless, preservative free and proven safe in clinical studies. In the most recent clinical study, over ninety percent of users saw improvement in nail appearance after 8 weeks, and more than three fourths saw improvement in appearance in just 2 weeks of use.
Kerasal Nail is easy to use, helping to ensure user compliance. It comes with a unique no-mess pinpoint silicone tip applicator, requires application just once a day, does not require filing of the nail, and dries quickly.
In a consumer research study of 500 fungal nail suffers, 77% said they would definitely or probably buy Kerasal Nail after seeing the concept. Alterna and Moberg are co-funding over $5 million worth of advertising and promotion to launch Kerasal Nail to the U.S. market, with heavy focus on television, print and consumer promotion. They expect to add at least $10 million of incremental retail sales to the category annually.